{"cluster": 43, "subcluster": 24, "abstract_summ": "We here report the successful recovery from coronavirus disease-19 (COVID-19) pneumonia in a patient with \u03b2-thalassemia major (\u03b2-TM) and severe pulmonary arterial hypertension (PAH), focusing on the patient's comorbidities, therapeutic course and drug interaction.We report a case of intravascular hemolysis and methemoglobinemia, precipitated by severe acute respiratory syndrome coronavirus 2 infection, in a patient with undiagnosed glucose-6-phosphate dehydrogenase deficiency.In this cohort of 42 patients with mild COVID19 we describe the unique clinical feature of acute anosmia and dysgeusia in more than third of patients.Median onset of these features was 3.3 days after onset of illness (range 0-7) with rapid recovery in most patient.In this paper, we report the results of plasmapheresis treatment in a series of severely ill patients with COVID-19\u2013related autoimmune meningoencephalitis in the Intensive Care Unit ICU.", "title_summ": "Anosmia and dysgeusia in patients with mild SARS-CoV-2 infectionG6PD Deficiency Overrepresented Among Pediatric COVID-19 Cases in One Saudi Children HospitalPlasmapheresis treatment in COVID-19\u2013related autoimmune meningoencephalitis: Case seriesCOVID-19 in a Patient with \u03b2-Thalassemia Major and Severe Pulmonary Arterial Hypertension.Methemoglobinemia in Patient with G6PD Deficiency and SARS-CoV-2 Infection.", "title_abstract_phrases": "G6PD Deficiency Overrepresented Among Pediatric COVID-19 Cases in One Saudi Children HospitalFluorescent spot test for glucose-6-phosphate dehydrogenase (G6PD) deficiency was performed in 5 boys and 14 girls who had confirmed COVID-19.We report a case of intravascular hemolysis and methemoglobinemia, precipitated by severe acute respiratory syndrome coronavirus 2 infection, in a patient with undiagnosed glucose-6-phosphate dehydrogenase deficiency.We here report the successful recovery from coronavirus disease-19 (COVID-19) pneumonia in a patient with \u03b2-thalassemia major (\u03b2-TM) and severe pulmonary arterial hypertension (PAH), focusing on the patient's comorbidities, therapeutic course and drug interaction.Anosmia and dysgeusia in patients with mild SARS-CoV-2 infectionIn this cohort of 42 patients with mild COVID19 we describe the unique clinical feature of acute anosmia and dysgeusia in more than third of patients.Median onset of these features was 3.3 days after onset of illness (range 0-7) with rapid recovery in most patient."}